A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT ID: NCT05047601

Last Updated: 2023-05-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

2954 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-09

Study Completion Date

2022-04-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection.

All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the experiences of people receiving the study medicines to those of the people who do not. This will help us determine if the study medicines are safe and effective

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Eligible participants who are asymptomatic household contacts of an individual with symptomatic COVID-19 will be randomized (1:1:1) to receive orally every 12 hours:

PF-07321332/ritonavir for 5 days followed by placebo for 5 days or PF-07321332/ritonavir for 10 days or Placebo for 10 days
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Double Blind Double Dummy

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PF-07321332/ritonavir (5 days)

Participants will receive PF-07321332/ritonavir every 12 hours from Day 1 through Day 5 followed by Placebo every 12 hours from Day 6 through Day 10

Group Type EXPERIMENTAL

PF-07321332

Intervention Type DRUG

PF-07321332

Placebo for PF-07321332

Intervention Type DRUG

Placebo

Placebo for Ritonavir

Intervention Type DRUG

Placebo

Ritonavir

Intervention Type DRUG

Ritonavir

PF-07321332/ritonavir (10-Day)

Participants will receive PF-07321332/ritonavir every 12 hours from Day 1 through Day 10.

Group Type EXPERIMENTAL

PF-07321332

Intervention Type DRUG

PF-07321332

Ritonavir

Intervention Type DRUG

Ritonavir

Placebo

Participants will receive placebo every 12 hours from Day 1 through Day 10.

Group Type PLACEBO_COMPARATOR

Placebo for PF-07321332

Intervention Type DRUG

Placebo

Placebo for Ritonavir

Intervention Type DRUG

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PF-07321332

PF-07321332

Intervention Type DRUG

Placebo for PF-07321332

Placebo

Intervention Type DRUG

Placebo for Ritonavir

Placebo

Intervention Type DRUG

Ritonavir

Ritonavir

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants who have a negative screening SARS-CoV-2 rapid antigen test result and who are asymptomatic household contacts with exposure within 96 hours to an individual who is symptomatic and recently tested positive for SARS CoV-2.
* Fertile participants must agree to use a highly effective method of contraception

Exclusion Criteria

* History of SARS-CoV-2 infection in the past 6 months
* Experiencing measured fever (documented temperature \>38˚C or 100.4˚F) or other signs or symptoms consistent with COVID-19
* Known medical history of active liver disease
* Chronic Kidney Disease or have known moderate to severe renal impairment.
* Known Human Immunodeficiency Virus (HIV) infection with viral load \> 400 copies/ml within the last 6 months or taking prohibited medications for HIV treatment
* Suspected or confirmed concurrent active systemic infection
* Active cancer requiring treatment with prohibited medication.
* Current or expected use of any medications or substances that are highly dependent on Cytochrome P450 3A4 (CYP3A4) for clearance or are strong inducers of CYP3A4
* Has received approved, authorized, or investigational anti-SARS-CoV-2 mAb, convalescent plasma, other drugs for treatment of COVID-19, or other anti-SARS-CoV-2 biologic products within 6 months of screening
* Has received any SARS-CoV-2 vaccine within 6 months prior to screening or is expected to receive a SARS-CoV-2 vaccine or other approved, authorized, or investigational postexposure prophylaxis treatments through Day 38.
* Participating in another interventional clinical study with an investigational compound or device, including those for COVID-19
* Known or prior participation in this trial or another trial involving PF-07321332.
* Females who are pregnant or breastfeeding.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cahaba Research Inc

Pelham, Alabama, United States

Site Status

The Institute for Liver Health dba Arizona Clinical Trials

Tucson, Arizona, United States

Site Status

Ascada Health PC

Fullerton, California, United States

Site Status

Optimus Medical Group

San Francisco, California, United States

Site Status

Synergy Healthcare

Bradenton, Florida, United States

Site Status

MOORE Clinical Research, Inc.

Brandon, Florida, United States

Site Status

TrueBlue Clinical Research

Brandon, Florida, United States

Site Status

Herco Medical and Research Center Inc

Coral Gables, Florida, United States

Site Status

Advance Clinical Research Group

Cutler Bay, Florida, United States

Site Status

Beautiful Minds Clinical Research Center

Cutler Bay, Florida, United States

Site Status

Qway Research

Hialeah, Florida, United States

Site Status

Eastern Research Inc

Hialeah, Florida, United States

Site Status

Inpatient Research Clinic

Hialeah, Florida, United States

Site Status

Doral Medical Research,LLC

Hialeah, Florida, United States

Site Status

Unlimited Medical Research Group, LLC

Hialeah Gardens, Florida, United States

Site Status

ASCLEPES Research Centers

Lutz, Florida, United States

Site Status

Angels Clinical Research Institute

Miami, Florida, United States

Site Status

LCC Medical Research Institute, LLC

Miami, Florida, United States

Site Status

Premium Medical Research Corp

Miami, Florida, United States

Site Status

Global Health Clinical Trials Corp

Miami, Florida, United States

Site Status

South Florida Research Center, Inc.

Miami, Florida, United States

Site Status

University of Miami Health System

Miami, Florida, United States

Site Status

I.V.A.M. Clinical & Investigational Center, LLC

Miami, Florida, United States

Site Status

Medical Research of Westchester Inc

Miami, Florida, United States

Site Status

C'A Research

Miami, Florida, United States

Site Status

ProLive Medical Research, Corp.

Miami, Florida, United States

Site Status

Entrust Clinical Research

Miami, Florida, United States

Site Status

Reed Medical Research

Miami, Florida, United States

Site Status

Kendall South Medical Center, Inc.

Miami, Florida, United States

Site Status

Clinical Site Partners, Inc dba CSP Miami

Miami, Florida, United States

Site Status

Coral Research Clinic Corp

Miami, Florida, United States

Site Status

Pro-Care Research Center, Corp.

Miami Gardens, Florida, United States

Site Status

Savin Medical Group, LLC

Miami Lakes, Florida, United States

Site Status

Omega Research Orlando

Orlando, Florida, United States

Site Status

NAPA Research LLC

Pompano Beach, Florida, United States

Site Status

CDC Research Institute, LLC

Port Saint Lucie, Florida, United States

Site Status

USPA Advance Concept Medical Research Group LLC

South Miami, Florida, United States

Site Status

ASCLEPES Research Centers

Spring Hill, Florida, United States

Site Status

GCP, Global Clinical Professionals

St. Petersburg, Florida, United States

Site Status

Sunrise Research Institute

Sunrise, Florida, United States

Site Status

Santos Research Center, CORP

Tampa, Florida, United States

Site Status

Research by Design, LLC

Chicago, Illinois, United States

Site Status

Accellacare

Ames, Iowa, United States

Site Status

McFarland Clinic, PC

Ames, Iowa, United States

Site Status

Southern Clinical Research Associates. LLC

Metairie, Louisiana, United States

Site Status

Meridian Clinical Research, LLC

Grand Island, Nebraska, United States

Site Status

Quality Clinical Research Inc

Omaha, Nebraska, United States

Site Status

Quality Clinical Research

Omaha, Nebraska, United States

Site Status

Walmart

Las Vegas, Nevada, United States

Site Status

Excel Clinical research

Las Vegas, Nevada, United States

Site Status

Walgreens

Las Vegas, Nevada, United States

Site Status

NYC Health + Hospitals / Harlem

New York, New York, United States

Site Status

Monroe Biomedical Research

Monroe, North Carolina, United States

Site Status

Innovo Research: Wilmington Health

Wilmington, North Carolina, United States

Site Status

PharmaTex Research, LLC

Amarillo, Texas, United States

Site Status

Conroe Willis Medical Research

Conroe, Texas, United States

Site Status

South Texas Clinical Research

Corpus Christi, Texas, United States

Site Status

SingnatureCare Emergency Center

Houston, Texas, United States

Site Status

Trio Clinical Trials, LLC

Houston, Texas, United States

Site Status

C & R Research Services USA

Houston, Texas, United States

Site Status

SMS Clinical Research, LLC

Mesquite, Texas, United States

Site Status

Epic Medical Research

Red Oak, Texas, United States

Site Status

Sun Research Institute

San Antonio, Texas, United States

Site Status

Tranquility Research

Webster, Texas, United States

Site Status

Instituto de Investigaciones Clinicas Zarate

Zárate, Buenos Aires, Argentina

Site Status

Instituto Médico de la Fundación Estudios Clínicos (Fundación Estudios Clínicos)

Rosario, Santa Fe Province, Argentina

Site Status

Pesquisare Saude S/S Ltda

Santo André, São Paulo, Brazil

Site Status

Conjunto Hospitalar do Mandaqui

São Paulo, , Brazil

Site Status

"Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd

Haskovo, , Bulgaria

Site Status

MHAT "Sv.Ivan. Rilski'' Kozloduy EOOD

Kozloduy, , Bulgaria

Site Status

Diagnostic-Consultative Center I Lom EOOD

Lom, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment- Sveti Nikolay Chudotvoretz EOOD

Lom, , Bulgaria

Site Status

Medical centre Leo Clinic EOOD

Lovech, , Bulgaria

Site Status

MHAT Heart and Brain EAD

Pleven, , Bulgaria

Site Status

DCC Sveti Georgi EOOD

Plovdiv, , Bulgaria

Site Status

MHAT "St. Panteleimon "- Plovdiv

Plovdiv, , Bulgaria

Site Status

UMHAT Medica Ruse OOD

Rousse, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment - Samokov EOOD

Samokov, , Bulgaria

Site Status

Multiprofile hospital for active treatment - Sliven to Military Medical Academy

Sliven, , Bulgaria

Site Status

Diagnostic-Consultative Center XXII- Sofia ЕООD

Sofia, , Bulgaria

Site Status

UMHATEM N. I. Pirogov EAD

Sofia, , Bulgaria

Site Status

Specialized hospital for active treatment in pulmonology and phthisiology "Stara Zagora" EOOD

Stara Zagora, , Bulgaria

Site Status

Medical center Leo Clinic EOOD

Varna, , Bulgaria

Site Status

MOBAL "D-r Stefan Cherkezov" AD

Veliko Tarnovo, , Bulgaria

Site Status

Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Vratsa EOOD

Vratsa, , Bulgaria

Site Status

Clinica de la Costa LTDA.

Barranquilla, Atlántico, Colombia

Site Status

Caimed S.A.S.

Yopal, Casanare Department, Colombia

Site Status

Cireem Sas

Bogota, Cundinamarca, Colombia

Site Status

Doktor Brno s.r.o.

Brno, , Czechia

Site Status

Zdraví-Fit, s.r.o.

Protivín, , Czechia

Site Status

Nemocnice Slany

Slaný, , Czechia

Site Status

Medifarma-98 Kft.

Nyíregyháza, , Hungary

Site Status

International University of Health and Welfare Narita Hospital

Narita, Chiba, Japan

Site Status

Rakuwakai Otowa Hospital

Kyoto, Kyoto, Japan

Site Status

Rinku General Medical Center

Izumisano, Osaka, Japan

Site Status

Denenchofu Family Clinic

Ōta-ku, Tokyo, Japan

Site Status

Sekino Hospital

Toshimaku, Tokyo, Japan

Site Status

Hospital Miri

Miri, Sarawak, Malaysia

Site Status

Clinical Research Institute Saltillo S.A. de C.V.

Saltillo, Coahuila, Mexico

Site Status

InfectoLab Consultorios de Especialidad en Infectologia

Tijuana, Estado de Baja California, Mexico

Site Status

Instituto Jalisciense de Metabolismo, S.C.

Guadalajara, Jalisco, Mexico

Site Status

Christus- Latam Hub Center of Excellence and Innovation Center S.C.

Monterrey, Nuevo León, Mexico

Site Status

Eukarya Pharmasite S.C.

Monterrey, Nuevo León, Mexico

Site Status

EME RED Hospitalaria

Mérida, Yucatán, Mexico

Site Status

Instituto de Investigaciones Clinicas para la Salud A.C.

Durango, , Mexico

Site Status

FAICIC Clinical Research

Veracruz, , Mexico

Site Status

Sociedad de Metabolismo y Corazon S.C.

Veracruz, , Mexico

Site Status

Centrum Badań Klinicznych Piotr Napora Lekarze Spółka Partnerska

Wroclaw, , Poland

Site Status

Kirovsk Interdistrict Hospital

Kirovsk, Leningradskaya Oblast', Russia

Site Status

LLC Trekhgorka Medicine

Odintsovo, Moscow Oblast, Russia

Site Status

Clinica UZI 4D

Pyatigorsk, Stavropol Kray, Russia

Site Status

Barnaul City Hospital Number 5

Barnaul, , Russia

Site Status

Korolev Medicine

Korolyov, , Russia

Site Status

KDC "Evromedservis", OJSC

Moscow, , Russia

Site Status

City Polyclinic #44

Saint Petersburg, , Russia

Site Status

City Polyclinic No. 109

Saint Petersburg, , Russia

Site Status

LLC Strategic Medical Systems

Saint Petersburg, , Russia

Site Status

City Out-patient clinic #112

Saint Petersburg, , Russia

Site Status

"Research Center Eco-safety" LLC

Saint Petersburg, , Russia

Site Status

LLC Kurator

Saint Petersburg, , Russia

Site Status

Saint-Petersburg State Budgetary Healthcare Institution "City Pokrovskaya hospital"

Saint Petersburg, , Russia

Site Status

City Out-patient clinic #4

Saint Petersburg, , Russia

Site Status

Smolensk State Medical University

Smolensk, , Russia

Site Status

LLC Family clinic

Yekaterinburg, , Russia

Site Status

MERC Welkom

Welkom, Free State, South Africa

Site Status

Worthwhile Clinical Trials

Benoni, Gauteng, South Africa

Site Status

LCS Clinical Research

Johannesburg, Gauteng, South Africa

Site Status

Peermed CTC (Pty) Ltd T/A MERC Kempton

Kempton Park, Gauteng, South Africa

Site Status

Global Clinical Trials

Pretoria, Gauteng, South Africa

Site Status

Botho Ke Bontle Health Services

Pretoria, Gauteng, South Africa

Site Status

About Allergy (PTY) Ltd

Pretoria, Gauteng, South Africa

Site Status

Into Research

Pretoria, Gauteng, South Africa

Site Status

Clinical Trial Systems (Pty) Ltd

Pretoria, Gauteng, South Africa

Site Status

Sandton Medical Clinic

Sandton, Gauteng, South Africa

Site Status

Synapta Clinical Research Center

Durban, KwaZulu-Natal, South Africa

Site Status

Dr PJ Sebastian Clinical Research Centre

Durban, KwaZulu-Natal, South Africa

Site Status

Ahmed Al-Kadi Private Hospital

Mayville, Durban, KwaZulu-Natal, South Africa

Site Status

Limpopo Clinical Research Initiative

Thabazimbi, Limpopo, South Africa

Site Status

NHC Thohoyandou CRS

Thohoyandou, Limpopo, South Africa

Site Status

MERC Middelburg

Middelburg, Mpumalanga, South Africa

Site Status

Madibeng Centre for Research

Brits, North West, South Africa

Site Status

FCRN Clinical Trial Centre

Vereeniging, , South Africa

Site Status

Complexo Hospitalario Universitario da Coruna

A Coruña, , Spain

Site Status

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),

Pathumwan, Bangkok, Thailand

Site Status

Faculty of Medicine - Khon Kaen University

Muang, Changwat Khon Kaen, Thailand

Site Status

King Chulalongkorn Memorial Hospital

Bangkok, , Thailand

Site Status

Faculty of Tropical Medicine, Mahidol University

Bangkok, , Thailand

Site Status

Tropical Medicine Hospital

Bangkok, , Thailand

Site Status

Ankara University Medical Faculty, Ibni-Sina Hospital

Ankara, , Turkey (Türkiye)

Site Status

Istanbul University Istanbul Medical Faculty

Fatih / Istanbul, , Turkey (Türkiye)

Site Status

Gaziantep Universitesi Tip Fakultesi Sahinbey Uygulama ve Arastirma Hastanesi

Gaziantep, , Turkey (Türkiye)

Site Status

Acibadem University Atakent Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Izmir Suat Seren Chest Disease and Surgery Training and Research Hospital

Izmir, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty

Mersin, , Turkey (Türkiye)

Site Status

Karadeniz Teknik Universitesi Farabi Hastanesi

Trabzon, , Turkey (Türkiye)

Site Status

Regional Communal Nonprofit Institution "Chernivtsi Regional Clinical Hospital"

Chernivtsi, , Ukraine

Site Status

Communal non-commercial Enterprise "City Central Clinical Hospital" of Chernivtsi City Council

Chernivtsi, , Ukraine

Site Status

Communal non-profit enterprise "City Clinical Hospital #16" of Dnipro City Council

Dnipro, , Ukraine

Site Status

Communal nonprofit enterprise "Central City Clinical Hospital of Ivano-Frankivsk City Council"

Ivano-Frankivsk, , Ukraine

Site Status

Municipal Non-profit Enterprise "Ivano-Frankivsk Regional Phthisiopulmonology Center of

Ivano-Frankivsk, , Ukraine

Site Status

Municipal Nonprofit Enterprise "City Student Hospital" of Kharkiv City Council

Kharkiv, , Ukraine

Site Status

Municipal Nonprofit Enterprise of Kharkiv Regional Council "Regional Clinical Infectious Diseases

Kharkiv, , Ukraine

Site Status

Municipal Nonprofit Enterprise "City Clinic Hospital # 13" of Kharkiv City Council

Kharkiv, , Ukraine

Site Status

Polyclinic of Center for Medical Services and Rehabilitation of State Joint-Stock Holding Company

Kyiv, , Ukraine

Site Status

Municipal Nonprofit Enterprise "Lviv City Clinic Hospital #4"

Lviv, , Ukraine

Site Status

Municipal NonProfit Enterprise of the Lviv Regional Council Lviv Regional Information and Analytical

Lviv, , Ukraine

Site Status

Municipal Nonprofit Enterprise "Lviv City Clinic Hospital #4"

Lviv, , Ukraine

Site Status

Municipal Enterprise "Poltava Regional Clinical Infectious Diseases Hospital" of Poltava Regional

Poltava, , Ukraine

Site Status

Municipal Enterprise "Volyn Regional Clinical Hospital" of Volyn Regional Council

Tarasove Village, , Ukraine

Site Status

Communal Enterprise "Hospital #1" of Zhytomyr City Council

Zhytomyr, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Bulgaria Colombia Czechia Hungary Japan Malaysia Mexico Poland Russia South Africa Spain Thailand Turkey (Türkiye) Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Hammond J, Yunis C, Fountaine RJ, Luscan G, Burr AM, Zhang W, Wisemandle W, Soares H, Baniecki ML, Hendrick VM, Kalfov V, Pypstra R, Rusnak JM. Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2024 Jul 18;391(3):224-234. doi: 10.1056/NEJMoa2309002.

Reference Type DERIVED
PMID: 39018532 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://pmiform.com/clinical-trial-info-request?StudyID=C4671006

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-002894-24

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

EPIC-PEP

Identifier Type: OTHER

Identifier Source: secondary_id

C4671006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.